Blog
BeOne Medicines Q2 Earnings Call Highlights
Key Points
- Interested in BeOne Medicines Ltd. - Sponsored ADR? Here are five stocks we like better.
- Strong second-quarter performance: BeOne Medicines reported revenue of $1.7 billion, up 30%
One Stop Systems Q2 Earnings Call Highlights
Key Points
- Interested in One Stop Systems, Inc.? Here are five stocks we like better.
- Strong growth and raised outlook: Second-quarter revenue from continuing operations rose 62.3% to $9.3
Orthofix Medical Q2 Earnings Call Highlights
Key Points
- Interested in Orthofix Medical Inc.? Here are five stocks we like better.
- Orthofix reported 5% pro forma constant-currency sales growth in the second quarter, supported by
Orion Energy Systems Q1 Earnings Call Highlights
Key Points
- Interested in Orion Energy Systems, Inc.? Here are five stocks we like better.
- Strong first-quarter performance: Revenue increased 32% year over year to $25.7 million, while net
Oaktree Specialty Lending Q3 Earnings Call Highlights
Key Points
- Interested in Oaktree Specialty Lending Corp.? Here are five stocks we like better.
- Credit quality improved: Non-accrual investments fell to 1.8% of the debt portfolio at fair value
NiCE Q2 Earnings Call Highlights
Key Points
- Interested in NiCE? Here are five stocks we like better.
- Second-quarter performance exceeded expectations: Revenue rose 8% year over year to $782 million, and adjusted EPS reached
Consumer Portfolio Services Q2 Earnings Call Highlights
Key Points
- Interested in Consumer Portfolio Services, Inc.? Here are five stocks we like better.
- Loan originations surged: Second-quarter originations rose more than 40% sequentially to $758
Ramaco Resources Q2 Earnings Call Highlights
Key Points
- Interested in Ramaco Resources, Inc.? Here are five stocks we like better.
- Second-quarter performance weakened: Adjusted EBITDA fell to $6 million from $9 million year over year as
Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Key Points
- Interested in Meta Platforms, Inc.? Here are five stocks we like better.
- Meta Platforms beat revenue estimates in Q2, but legal and severance expenses drove a steep EPS miss and
NewAmsterdam Pharma Maps Obicetrapib Strategy as PREVAIL Interim Nears
Key Points
- Interested in NewAmsterdam Pharma Company N.V.? Here are five stocks we like better.
- PREVAIL is the key near-term catalyst: NewAmsterdam expects to reach its interim event target by
Medline Q2 Earnings Call Highlights
Key Points
- Interested in Medline? Here are five stocks we like better.
- Medline reported strong second-quarter growth, with net sales up 12% to $7.7 billion, led by a 16% increase in Supply
Limbach Q2 Earnings Call Highlights
Key Points
- Interested in Limbach Holdings, Inc.? Here are five stocks we like better.
- Second-quarter profitability weakened despite revenue rising 22% to $173.5 million, as gross margin fell to
Lineage Q2 Earnings Call Highlights
Key Points
- Interested in Lineage, Inc.? Here are five stocks we like better.
- Second-quarter results exceeded expectations: Adjusted EBITDA was approximately $320 million and AFFO was $198
LivaNova Q2 Earnings Call Highlights
Key Points
- Interested in LivaNova PLC? Here are five stocks we like better.
- Record Q2 performance: Revenue rose 9.8% year over year on a constant-currency basis to $391 million, while adjusted
Kymera Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Kymera Therapeutics, Inc.? Here are five stocks we like better.
- KT-621 atopic dermatitis trial enrollment is complete about six months ahead of schedule, with top-line
J & J Snack Foods Q3 Earnings Call Highlights
Key Points
- Interested in J & J Snack Foods Corp.? Here are five stocks we like better.
- Fiscal Q3 results weakened: Net sales fell 6.2% to $426 million, adjusted EBITDA declined 6.4% to $67.4
Interparfums Q2 Earnings Call Highlights
Key Points
- Interested in Interparfums, Inc.? Here are five stocks we like better.
- Interparfums maintained its 2026 outlook for approximately $1.48 billion in sales and diluted EPS of $4.85
CorVel Q1 Earnings Call Highlights
Key Points
- Interested in CorVel Corp.? Here are five stocks we like better.
- CorVel reported strong fiscal first-quarter results: Revenue rose 11% year over year to $260 million, EPS increased
Avnet Q4 Earnings Call Highlights
Key Points
- Interested in Avnet, Inc.? Here are five stocks we like better.
- Record fourth-quarter results: Avnet reported fiscal 2026 Q4 sales of $8.3 billion, up 48% year over year, and
AMD’s Post-Earnings Drop May Be the Opportunity Investors Wanted
Key Points
- Interested in Advanced Micro Devices, Inc.? Here are five stocks we like better.
- AMD's stock pulled back after a beat-and-raise earnings report, with revenue reaching $11.5 billion, up
Innospec Q2 Earnings Call Highlights
Key Points
- Interested in Innospec Inc.? Here are five stocks we like better.
- Strong second-quarter results: Revenue increased 12% to $491.4 million and net income rose to $30.8 million, with
Icahn Enterprises Q2 Earnings Call Highlights
Key Points
- Interested in Icahn Enterprises L.P.? Here are five stocks we like better.
- Second-quarter results worsened: Icahn Enterprises reported a $355 million net loss, or $0.52 per
International General Insurance Q2 Earnings Call Highlights
Key Points
- Interested in International General Insurance Holdings Ltd.? Here are five stocks we like better.
- War-related losses significantly reduced earnings: IGI recorded nearly $14 million
Innoviz Technologies Q2 Earnings Call Highlights
Key Points
- Interested in Innoviz Technologies Ltd.? Here are five stocks we like better.
- Record Q2 revenue reached $18.1 million, driven by higher non-recurring engineering revenue tied to
Ferroglobe Q2 Earnings Call Highlights
Key Points
- Interested in Ferroglobe PLC? Here are five stocks we like better.
- Ferroglobe’s Q2 performance improved sequentially: Shipments rose 7% to 188,000 tons, revenue increased 9% to $379

